Biogen quarterly sales rise 9 percent

Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.

Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news